Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy.

Jarrett, Jennie B

Bratberg, Jeffrey

Burns, Anne L

Cochran, Gerald

DiPaula, Bethany A

Legreid Dopp, Anna

Elmes, Abigail

Green, Traci C

Hill, Lucas G

Homsted, Felicity

Hsia, Stephanie L

Matthews, Michele L

Ghitza, Udi E

Wu, Li-Tzy

Bart, Gavin

2023-11-08T20:28:17Z

2023-11-08T20:28:17Z

2023-10

2023-11-08T20:28:16Z

In the last decade, the U.S. opioid overdose crisis has magnified, particularly since the introduction of synthetic opioids, including fentanyl. Despite the benefits of medications for opioid use disorder (MOUD), only about a fifth of people with opioid use disorder (OUD) in the U.S. receive MOUD. The ubiquity of pharmacists, along with their extensive education and training, represents great potential for expansion of MOUD services, particularly in community pharmacies. The National Institute on Drug Abuse's National Drug Abuse Treatment Clinical Trials Network (NIDA CTN) convened a working group to develop a research agenda to expand OUD treatment in the community pharmacy sector to support improved access to MOUD and patient outcomes. Identified settings for research include independent and chain pharmacies and co-located pharmacies within primary care settings. Specific topics for research included adaptation of pharmacy infrastructure for clinical service provision, strategies for interprofessional collaboration including health service models, drug policy and regulation, pharmacist education about OUD and OUD treatment, including didactic, experiential, and interprofessional curricula, and educational interventions to reduce stigma towards this patient population. Together, expanding these research areas can bring effective MOUD to where it is most needed.

0889-7077

1547-0164

https://hdl.handle.net/10161/29358

eng

SAGE Publications

Substance abuse

10.1177/08897077231203849

addiction treatment

buprenorphine

methadone

opioid use disorder

research priorities

Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy.

Journal article

Wu, Li-Tzy|0000-0002-5909-2259

8897077231203849

Duke

Sanford School of Public Policy

School of Medicine

Clinical Science Departments

Medicine

Psychiatry & Behavioral Sciences

Medicine, General Internal Medicine

Institutes and Provost's Academic Units

University Institutes and Centers

Duke Institute for Brain Sciences

Psychiatry, Child & Family Mental Health & Community Psychiatry

Center for Child and Family Policy

Published